ESOP scheme, re-appointment of directors, appointment of secretarial auditor
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech's board, at its May 28, 2025 meeting, approved the introduction of 'Fermenta Biotech Limited – Employee Stock Option Scheme 2025' covering up to 5,00,000 equity shares of ₹5 face value, to be implemented through an irrevocable ESOP Trust via secondary acquisition. The board also approved the re-appointment of two existing Executive Directors (both Key Managerial Personnel) – Ms. Anupama Datla Desai and Mr. Satish Varma – each for a three-year term effective September 27, 2025, subject to shareholder approval. Additionally, Mr. Vinayak Deodhar of V.N. Deodhar & Co., Company Secretaries, was appointed as Secretarial Auditor for five consecutive financial years from April 1, 2025 to March 31, 2030.
This is largely routine corporate housekeeping. The ESOP scheme, once approved by shareholders, will create a modest potential dilution of up to 5 lakh shares and align employee incentives with shareholders. The re-appointments provide continuity at the executive level, and the long-term secretarial auditor appointment strengthens governance consistency. No material adverse impact on shareholders is indicated.